← Leaderboards
Biao He
Pennsylvania State University-Univ Park
$13,478,803
Attributed
$17,666,830
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–21$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$17,666,830 · 11
By mechanism
R01$16,041,194 · 7
R21$809,426 · 2
K02$519,210 · 1
R56$297,000 · 1
Top collaborators
- Robert J Hogan6 shared
- Eric R Lafontaine6 shared
- Ming Luo4 shared
- Paul W. Spearman4 shared
Others in their field
Top investigators on “Paramyxovirus”
- Thomas William Geisbert · Boston University Medical Campus$29,343,162
- Anne Moscona · Mount Sinai School Of Medicine Of Nyu$27,091,846
- Christopher Broder · Henry M. Jackson Fdn For The Adv Mil/Med$19,756,755
- Benhur Lee · University Of Pennsylvania$18,466,031
- Richard K. Plemper · Georgia State University$17,177,113
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
Research focus
ParamyxovirusVirusBaseInfectionCellsRecombinantsProteinsVaccinesParainfluenza VirusLifePathogenImmunizationDoseGenomeAttenuatedVaccine DevelopmentImmunogenicityImmunityVaccinatedCanis FamiliarisGenesRecombinant VirusCoughingPathogenesis
Grant awards (45)
Pathogenesis of Jeilongvirus$471,160
R01 · FY2021 · AI · contact PI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$532,412
R01 · FY2020 · AI · contact PI
Pathogenesis of Jeilongvirus$471,179
R01 · FY2020 · AI · contact PI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$34,708
R01 · FY2020 · AI · contact PI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$658,990
R01 · FY2019 · AI · contact PI
Pathogenesis of Jeilongvirus$471,179
R01 · FY2019 · AI · contact PI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$716,802
R01 · FY2018 · AI · contact PI
Pathogenesis of Jeilongvirus$471,179
R01 · FY2018 · AI · contact PI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$619,634
R01 · FY2017 · AI · contact PI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$597,176
R01 · FY2017 · AI
Pathogenesis of Jeilongvirus$483,505
R01 · FY2017 · AI · contact PI
A Novel Vaccine for Burkholderia pseudomallei and Burkholderia mallei$31,863
R01 · FY2017 · AI · contact PI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$715,150
R01 · FY2016 · AI
Mechanism of Paramyxovirus Replication$571,779
R01 · FY2016 · AI
Developing a Novel Mumps Virus Vaccine$371,250
R01 · FY2016 · AI · contact PI
DEVELOPING A NOVEL VIRAL VECTOR FOR A HUMAN MALARIA VACCINE$225,000
R21 · FY2016 · AI · contact PI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$670,092
R01 · FY2015 · AI
Mechanism of Paramyxovirus Replication$582,127
R01 · FY2015 · AI
Developing a Novel Mumps Virus Vaccine$371,250
R01 · FY2015 · AI · contact PI
DEVELOPING A NOVEL VIRAL VECTOR FOR A HUMAN MALARIA VACCINE$187,188
R21 · FY2015 · AI · contact PI
Mucosal Protection Against HIV Generated by PIV5 Priming and VLP Boosting$682,842
R01 · FY2014 · AI
Mechanism of Paramyxovirus Replication$559,917
R01 · FY2014 · AI
Developing a Novel Mumps Virus Vaccine$371,250
R01 · FY2014 · AI · contact PI
A Novel Approach for Mycobacterium Tuberculosis Vaccine Development$222,750
R21 · FY2014 · AI · contact PI
Mechanism of Paramyxovirus Replication$537,760
R01 · FY2013 · AI
Developing a Novel Mumps Virus Vaccine$348,975
R01 · FY2013 · AI · contact PI
A Novel Approach for Mycobacterium Tuberculosis Vaccine Development$174,488
R21 · FY2013 · AI · contact PI
Developing a Paramyxovirus-based H5N1 Vaccine$722,969
R01 · FY2012 · AI · contact PI
Developing a Novel Mumps Virus Vaccine$371,250
R01 · FY2012 · AI · contact PI
Developing a Paramyxovirus-based H5N1 Vaccine$709,610
R01 · FY2011 · AI · contact PI
Developing a Paramyxovirus-based H5N1 Vaccine$658,661
R01 · FY2010 · AI · contact PI
Roles of Host Kinases in Paramyxovirus RNA Synthesis$297,000
R56 · FY2010 · AI · contact PI
Pathogenesis of Mumps Virus$103,842
K02 · FY2010 · AI · contact PI
Developing a Paramyxovirus-based H5N1 Vaccine$528,955
R01 · FY2009 · AI · contact PI
Pathogenesis of Mumps Virus$103,842
K02 · FY2009 · AI · contact PI
Developing a Paramyxovirus-based H5N1 Vaccine$515,639
R01 · FY2008 · AI · contact PI
Pathogenesis of Mumps Virus$103,842
K02 · FY2008 · AI · contact PI
Activation and Inhibition of Apoptotic Pathways by SV5$276,774
R01 · FY2007 · AI · contact PI
Pathogenesis of Mumps Virus$103,842
K02 · FY2007 · AI · contact PI
Activation and Inhibition of Apoptotic Pathways by SV5$285,840
R01 · FY2006 · AI · contact PI
Pathogenesis of Mumps Virus$103,842
K02 · FY2006 · AI · contact PI
Activation and Inhibition of Apoptotic Pathways by SV5$241,624
R01 · FY2005 · AI
Activation and Inhibition of Apoptotic Pathways by SV5$27,700
R01 · FY2005 · AI
Activation and Inhibition of Apoptotic Pathways by SV5$242,568
R01 · FY2004 · AI
Activation and Inhibition of Apoptotic Pathways by SV5$117,425
R01 · FY2003 · AI